Study identification

EU PAS number

EUPAS38515

Study ID

48631

Official title and acronym

Real world evidence of the usage of tofacitinib in Ulcerative Colitis patients in Lebanon

DARWIN EU® study

No

Study countries

Lebanon

Study description

A retrospective cohort study that describes the effectiveness of tofacitinib for the treatment of patients with ulcerative colitis in Lebanon.

Study status

Finalised
Research institutions and networks

Institutions

Pfizer
First published:
01/02/2024
Institution
American University of Beirut

Contact details

Owens Edie

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Pharmaceutical company and other private sector 

More details on funding

Pfizer
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable